Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Improvement in Post-Transplant Outcomes over Four Decades in Patients with Myelofibrosis | Synapse
March 3, 2026
Improvement in Post-Transplant Outcomes over Four Decades in Patients with Myelofibrosis
RS
Rachel B. Salit
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
XF
Xinyi Fan
South China Agricultural University
TR
Tim R Randolph
Fred Hutch Cancer Center
Puntos clave
Post-transplant survival rates show significant improvement over the last four decades, indicating better treatment strategies.
Analysis of over 300 cases revealed a 35% increase in five-year survival rates in patients with myelofibrosis after transplant.
Longitudinal analysis highlighted changes in pre-transplant conditions, leading to better outcomes in myelofibrosis treatment.
These findings suggest a continuous improvement in clinical practices and patient care over the years.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Salit et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7607fc6e9836116a2d4d2
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.571
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir